A framework for decision making of migraine treatment with anti- CGRP monoclonal antibodies: a guide for real-world practice and public policies. Headache Medicine, [S. l.], v. 11, n. 3, p. 72–76, 2020. DOI: 10.48208/HeadacheMed.2020.20. Disponível em: https://headachemedicine.com.br/hm/article/view/414. Acesso em: 22 jan. 2026.